Dynavax Technologies | Ventes



Sales Changement Date
AbbVie USD 15.42B 2.08B 2025-06
Adma Biologics USD 117.55M 2.29M 2024-12
Amgen USD 8.15B 936M 2025-03
AstraZeneca USD 14.46B 867M 2025-06
Biogen USD 2.6B 170M 2025-06
BioMarin Pharmaceutical USD 825M 80M 2025-06
Bristol-Myers Squibb USD 12.27B 1.07B 2025-06
Dynavax Technologies USD 65M 7.03M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
Glaxosmithkline GBP 8.12B 105M 2024-12
Merck USD 15.81B 280M 2025-06
Neurocrine Biosciences USD 687.5M 114.9M 2025-06
Novartis USD 14.05B 821M 2025-06
Pfizer USD 14.7B 980M 2025-06
Regeneron Pharmaceuticals USD 3.68B 650M 2025-06
Roche Holding CHF 31.64B 883M 2024-12
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
TG Therapeutics USD 141.1M 21.4M 2025-06
Vertex Pharmaceuticals USD 2.96B 190M 2025-06


Dynavax Technologies Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.